Download Fact Sheet:

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Private equity in the 2000s wikipedia , lookup

Environmental, social and corporate governance wikipedia , lookup

Socially responsible investing wikipedia , lookup

Investment banking wikipedia , lookup

Early history of private equity wikipedia , lookup

History of investment banking in the United States wikipedia , lookup

Private money investing wikipedia , lookup

Investment management wikipedia , lookup

Transcript
Fact Sheet:
DAN VICKERY
Cell: 412-877-7944
Website: www.BioEnsemble.com
Email: [email protected]
Profile:

An accomplished Business Development (BD) executive and Deal-Maker with a wide network of
contacts in Pharma, Specialty-Pharma, Biotech and Finance, with a special expertise in organization
and effective management, and exposure to many therapy areas, dosage forms and drug types.

Focuses on providing (BD) and strategic consulting services to a wide range of pharma and biotech
clients, many of whom enjoy successful alliances as a result of his services.

Independent financier/fundraiser, identifying and raising money for attractive private and public
investment ventures across industries, ranging from performing arts, through to mining, and biotech.
Education:
MBA, Executive Program, 2002; Richard Ivey School of Business, University of Western Ontario, London
Ph.D. (Genetics), 1990; B.Sc. (Biology) 1986; University of British Columbia, Vancouver
Experience:
Licensing, Business Development, and Commercial Strategy:
With a start in BD at Parke-Davis in 1998 as a development opportunity, currently have 10 years BD and
commercial strategy experience, including strategic marketing, forecasting, market research and international
marketing expertise in roles of increasing seniority/complexity; culminating in 9 deals:
Title
BD Consultant
Director, BD
Director Commercial Development
Associate Director New BD
Company
Self Employed
Bertek/Mylan
Pharmacia
Parke-Davis
Location
PA/NJ
PA/NC
NJ
Canada
Timing
2005-Present
2003-2005
2001-2003
1998-2000
Deals
2
3
2
2
Company Management/Corporate:
During 15 years of significant positions in the Pharmaceutical industry, management experience includes Big
Pharma, Specialty Pharma, small Biotech and international positions. As many as 10 direct reports were
managed as head of an international regulatory affairs (RA) department. Board experience includes a seat at CLevel Bio, and as Chairperson of the Canadian Association of Professional RA for 2 years.
Fundraising/Financing:
Integral member of consortia that have raised over $10 MM from private investors for a number of strategic
investment opportunities, and many investors have seen significant returns. Continually in search of unique
opportunities worthy of investment, and investors keen to fund these exciting projects.
Project
Xanadu on Broadway
C Level BIO
Book of Love Film
Raise
$4MM
$6MM
$600 K
Timing
2005-7
2006-7
2002-3
Outcome
Currently playing on Broadway, rave reviews
Currently worth $20MM, 300% return on IPO
Sundance entry and Showtime feature, Video
Pharmaceutical Development:
R&D career culminated in 1998 as head of Rx drug Regulatory Affairs for Parke-Davis in Canada:
Title
Manager, Associate Director RA
Manager, RA and Technical Affairs
Company
Parke-Davis
Kabi-Pharmacia
Location
Canada
Canada
Timing
1993-1998
1991-1992
Professional Affiliations:
Member, Licensing Executive Society, 2002 – Present;
Member, American Association for the Advancement of Science, 1990 – Present;
Chairperson, Canadian Association of Professional Regulatory Affairs (CAPRA), 1997 – 1999
NDAs/INDs
15
2